Bakery

Japan is awaiting further in-depth info on extent of GMO wheat in US before it opens imports

Japan calls for more GMO info before lifting US wheat ban

By Kacey Culliney

Japan will not lift its ban on US Western White wheat imports until the American government provides detailed information on the extent of unauthorized genetically modified wheat found in Oregon, a government official says.

Annual quinoa producer prices at farm gate in Peru 2000-11 in real terms (2005=100)

FAO asks: Could quinoa become a worldwide staple?

By Caroline SCOTT-THOMAS

Quinoa’s relatively high price compared to staple grains may restrict consumption to health-conscious consumers in high-income countries for now – but it could play an important role in food security in the long term, according to the FAO.

Ethical Business: Women’s rights on cocoa farms

Special Report

Ethical Business: Women’s rights on cocoa farms

This is the story of how an initiative from Oxfam prompted assurances from leading chocolate companies to improve the lives of women cocoa farmers. How did each firm react? Were they quick and effective enough?

New owners need to move quickly or risk being 'out of sight, out of mind' says Hudak

THE BANKRUPTCY THAT ROCKED THE MARKET

Hostess sales tot up $860m

By Kacey Culliney

Hostess Brands has closed all asset sales and pulled in $860m; a figure a little less than the worth of the company but expected given the speed of the sell-offs, an analyst says.

Food-grade sorghum confirmed safe for celiac sufferers - backed with genetic and biochemical evidence

Sorghum is celiac-safe: Study

By Kacey Culliney

The cereal grain sorghum is a safe food for consumers with celiac disease and therefore ideal for gluten-free formulations, new research finds.

CSM confirmed $1.05bn sale of bakery supplies to private equity today

BILLION DOLLAR BAKERY DIVESTMENT CONFIRMED

Eight months later: CSM sells bakery supplies for $1.05bn

By Kacey Culliney

CSM has agreed to sell its bakery supplies businesses to private equity firm Rhône Capital for $1.05bn, eight months after its announcement to reposition as a bio-based ingredients firm.

Follow us

Products

View more

Webinars